Geoffrey T. Tucker

15.7k total citations · 2 hit papers
190 papers, 12.0k citations indexed

About

Geoffrey T. Tucker is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Geoffrey T. Tucker has authored 190 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pharmacology, 48 papers in Oncology and 30 papers in Pharmacology. Recurrent topics in Geoffrey T. Tucker's work include Pharmacogenetics and Drug Metabolism (93 papers), Drug Transport and Resistance Mechanisms (42 papers) and Anesthesia and Pain Management (25 papers). Geoffrey T. Tucker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (93 papers), Drug Transport and Resistance Mechanisms (42 papers) and Anesthesia and Pain Management (25 papers). Geoffrey T. Tucker collaborates with scholars based in United Kingdom, United States and Australia. Geoffrey T. Tucker's co-authors include Amin Rostami‐Hodjegan, M. S. Lennard, Trevor N. Johnson, Masoud Jamei, Laurence E. Mather, Karen Rowland Yeo, S. W. Ellis, Jiansong Yang, Malcolm Rowland and Carl C. Peck and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Geoffrey T. Tucker

189 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science

2011 465 citations Geoffrey T. Tucker et al. profile →
The Simcyp ^® Population-based ADME Simulator

2009 406 citations Masoud Jamei, Kairui Feng et al. Expert Opinion on Drug Metabolism & Toxicology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geoffrey T. Tucker United Kingdom	58	4.9k	2.8k	2.0k	1.8k	1.8k	190	12.0k
Kim Brøsen Denmark	62	4.8k 1.0×	2.2k 0.8×	1.8k 0.9×	1.8k 1.0×	2.4k 1.3×	233	11.0k
Malcolm Rowland United Kingdom	65	5.6k 1.1×	4.7k 1.7×	2.5k 1.2×	2.9k 1.6×	2.8k 1.6×	293	16.0k
Danny D. Shen United States	56	3.7k 0.8×	3.0k 1.1×	3.3k 1.6×	1.6k 0.9×	1.2k 0.6×	223	12.1k
William J. Jusko United States	64	3.2k 0.7×	2.6k 1.0×	2.6k 1.3×	4.3k 2.4×	2.9k 1.6×	538	18.6k
Leif Bertilsson Sweden	71	8.7k 1.8×	3.8k 1.4×	3.1k 1.5×	2.6k 1.4×	3.5k 2.0×	292	17.5k
Meindert Danhof Netherlands	61	2.4k 0.5×	2.0k 0.7×	3.3k 1.6×	3.5k 1.9×	2.7k 1.5×	496	15.3k
Pierre Dayer Switzerland	55	3.2k 0.7×	1.6k 0.6×	1.2k 0.6×	1.8k 1.0×	1.6k 0.9×	202	8.8k
Jürgen Brockmöller Germany	65	5.1k 1.0×	4.0k 1.4×	2.7k 1.3×	4.0k 2.2×	1.6k 0.9×	236	13.8k
Stephen D. Hall United States	63	6.4k 1.3×	4.4k 1.6×	2.2k 1.1×	2.2k 1.2×	1.3k 0.7×	217	14.1k
Takashi Ishizaki Japan	54	4.0k 0.8×	2.2k 0.8×	1.4k 0.7×	1.7k 1.0×	1.3k 0.7×	296	10.0k

Countries citing papers authored by Geoffrey T. Tucker

Since Specialization

Citations

This map shows the geographic impact of Geoffrey T. Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey T. Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey T. Tucker more than expected).

Fields of papers citing papers by Geoffrey T. Tucker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey T. Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey T. Tucker. The network helps show where Geoffrey T. Tucker may publish in the future.

Co-authorship network of co-authors of Geoffrey T. Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey T. Tucker. A scholar is included among the top collaborators of Geoffrey T. Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey T. Tucker. Geoffrey T. Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Bo, et al.. (2016). The absorption kinetics of ketoconazole plays a major role in explaining the reported variability in the level of interaction with midazolam: Interplay between formulation and inhibition of gut wall and liver metabolism. Biopharmaceutics & Drug Disposition. 38(3). 260–270. 12 indexed citations

Barter, Zoe, Geoffrey T. Tucker, & K Rowland‐Yeo. (2013). Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling. Clinical Pharmacokinetics. 52(12). 1085–1100. 101 indexed citations

Jamei, Masoud, et al.. (2009). The Simcyp ^® Population-based ADME Simulator. Expert Opinion on Drug Metabolism & Toxicology. 5(2). 211–223. 406 indexed citations breakdown →

Ghanbari, Farshid, K Rowland‐Yeo, J. C. Bloomer, et al.. (2006). A Critical Evaluation of the Experimental Design of Studies of Mechanism Based Enzyme Inhibition, with Implications for In Vitro-In Vivo Extrapolation. Current Drug Metabolism. 7(3). 315–334. 95 indexed citations

Yeo, Karen Rowland, et al.. (2004). MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE. Drug Metabolism and Disposition. 32(11). 1213–1217. 71 indexed citations

Mah, Peak Mann, Richard C. Jenkins, Amin Rostami‐Hodjegan, et al.. (2004). Weight‐related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology. 61(3). 367–375. 195 indexed citations

Johnson, Trevor N., Amin Rostami‐Hodjegan, Anupam Chakrapani, et al.. (2002). An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. British Journal of Clinical Pharmacology. 54(2). 140–146. 22 indexed citations

Rostami‐Hodjegan, Amin, Mohammad Bagher Shiran, Geoffrey T. Tucker, et al.. (2002). A New Rapidly Absorbed Paracetamol Tablet Containing Sodium Bicarbonate. II. Dissolution Studies and In Vitro/In Vivo Correlation. Drug Development and Industrial Pharmacy. 28(5). 533–543. 30 indexed citations

Johnson, Trevor N., M S Tanner, & Geoffrey T. Tucker. (2000). A comparison of the ontogeny of enterocytic and hepatic cytochromes P450 3A in the rat. Biochemical Pharmacology. 60(11). 1601–1610. 37 indexed citations

10.

Lightfoot, J. Timothy, S. W. Ellis, Mark J. Ackland, et al.. (2000). Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling. Xenobiotica. 30(3). 219–233. 32 indexed citations

11.

Rostami‐Hodjegan, Amin, Steven R. Peacey, Eric M. George, Simon Heller, & Geoffrey T. Tucker. (1998). Population-based modeling to demonstrate extrapancreatic effects of tolbutamide. American Journal of Physiology-Endocrinology and Metabolism. 274(4). E758–E771. 10 indexed citations

12.

Tucker, Geoffrey T., Amin Rostami‐Hodjegan, & Paul R. Jackson. (1998). Determination of drug-metabolizing enzyme activity in vivo : pharmacokinetic and statistical issues. Xenobiotica. 28(12). 1255–1273. 36 indexed citations

13.

Ellis, S. W., Mark J. Ackland, Eleni A. Rekka, et al.. (1996). Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochemical Journal. 316(2). 647–654. 57 indexed citations

14.

Ching, Michael S., Hany Ghabrial, S. W. Ellis, et al.. (1995). Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites. Biochemical Pharmacology. 50(6). 833–837. 48 indexed citations

15.

Jackson, Peter R., Alan R. Boobis, & Geoffrey T. Tucker. (1991). Phenotype or genotype. British Journal of Clinical Pharmacology. 31(1). 119–120. 2 indexed citations

16.

Rice, Andrew S.C., Charles E. Pither, & Geoffrey T. Tucker. (1991). Plasma concentrations of bupivacaine after supraclavicular brachial plexus blockade in patients with chronic renal failure. Anaesthesia. 46(5). 354–357. 14 indexed citations

17.

Lennard, M. S., et al.. (1984). Disopyramide elimination in the isolated perfused rat liver. Xenobiotica. 14(11). 885–892. 1 indexed citations

18.

Holt, David W., Geoffrey T. Tucker, Peter R. Jackson, & G. Storey. (1983). Amiodarone pharmacokinetics. American Heart Journal. 106(4). 840–847. 336 indexed citations

19.

Pflug, A. Eugene, Terence M. Murphy, Stephen Butler, & Geoffrey T. Tucker. (1974). The Effects of Postoperative Peridural Analgesia on Pulmonary Therapy and Pulmonary Complications. Anesthesiology. 41(1). 8–17. 78 indexed citations

20.

Tucker, Geoffrey T. & R Boas. (1971). Pharmacokinetic Aspects of Intravenous Regional Anesthesia. Anesthesiology. 34(6). 538–549. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact